Aptamer Group plc, the developer of novel Optimer binders, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus on ...

SPARK Neuro, a startup in the emerging field of neuroscience-based analytics, has closed $13.5 million in Series A funding led by Thiel Capital’s Peter Thiel with participation other investors ...

Aptamer Group plc is pleased to announce the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA), a format widely accepted and ...

HG Wells predicted that our future would be a race between education and catastrophe. In this era of increasing emphasis on standardized tests, mounting competition for high quality, affordable ...

MANILA, Philippines – The Land Transportation Office (LTO) plans to require driver's license applicants to go through a neuro-psychiatric test, along with the mandatory drug and health examination, to ...